Investors

Investor Facts

Optos plc is a leading retinal imaging company with a vision to be recognized as the leading provider of retinal diagnostics through leveraging its unique ultra-widefield imaging technology.

Over 35 million optomap exams have been performed worldwide, helping us to secure our leading position in retinal diagnostics

Investor Factsheets

Download An Introduction to Optos - Building The Retina Company

Quick facts

Founded in 1992, IPO on LSE Main Market 2006. Operations in North America, Europe and Australia
Over 37 million optomap exams performed to date
Initially, devices used primarily in "wellness screening" to verify eye health. Newer devices with increased functionality used in treatment regimes
82% of Optos' business is in the North America. We are growing quickly in Europe and expanding into new markets through new distribution channels and directly in Australia
95% of Optos' revenue is from the core optometry sector with growing presence in ophthalmology
Optos has < 20% market penetration in 'target sectors' in existing markets - providing significant growth potential